A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler

European Journal of Clinical Pharmacology

Volumn 52, Issue 4, 1997, Pages 261-267

  Grahnen A ^a   Jansson, B ^b   Brundin, R M ^a   Ling Andersson, A ^a   Lonnebo A ^a   Johansson, M ^a   Eckernas S A ^a  

^a IQVIA   (United States)

^b Child and Adol Psychiatric Clinics   (Sweden)

Author keywords

Asthma; Budesonide; Children; Corticosteroids; Fluticasone propionatei; HPA axis; Plasma cortisol suppression; Systemic effects

Indexed keywords

BUDESONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADMINISTRATION, INHALATION; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; AREA UNDER CURVE; BUDESONIDE; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCORTISONE; MALE; MULTIVARIATE ANALYSIS; PREGNENEDIONES; REGRESSION ANALYSIS;

EID: 0030874197     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050287     Document Type: Article

References (16)

1. Toogood JH, Baskerville J, Jennings B, Lefcoe N, Johansson SÅ (1989) Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 84: 668-670
2. English AF, Neate MS, Quint DJ, Sareen (1994) Biological activities of some corticosteroids used in asthma. Am J Respir Crit Care Med 149: A212
3. Pedersen S, Fuglsang G (1988) Urine cortisol excretion in children treated with high doses of inhaled corticosteroids: a comparison of budesonide and beclomethasone. Eur Respir J 1: 433-435
4. Ayers JG, Bateman ED, Lundbäck B, Harris TA (1995) High dose fluticasone propionate 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 8: 579-586
5. Agertoft L, Pedersen S (1996) A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. Am J Respir Crit Care Med 153: A408
6. Grahnén A, Eckernäs S-Å, Brundin RM, Ling-Andersson A (1994) An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 38: 521-525
7. Lönnebo A, Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Eckernäs S-Å (1996) An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol 49: 459-463
8. Boorsma M, Andersson N, Larsson P, Ullman A (1996) Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur J Respir 9: 1427-1432
9. Clark D, Grove A, Cargill RI, Coutie WJ, Lipworth BJ (1995) Increased adrenal suppression with fluticasone propionate(F) versus budesonide(B) given by MDI in asthmatics. Eur Respir J 8 [Suppl 19]: 1528
10. Grove A, Allam C, McFarlane L, McPhale G, Lipworth B (1994) A comparison of the systemic bio-activity of inhaled budesonide and fluticasone propionate in normal subjects. Br J Clin Pharmacol 38: 527-532
11. Thorsson L, Edsbäcker S, Conradson T-B (1994) Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose Inhaler p-MDI. Eur Respir J 7: 1839-1844
12. Thorsson L, Dahlström K, Edsbacker S, Källén A, Paulson J, Wirén J-E (1997) Phamacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol 43: 155-161
13. Bain BM, Harrison G, Jenkins KD, Pateman AJ, Shenoy EVB (1993) A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. J Pharm Biomed Anal 13: 557-561
14. Fuller R, Johnson M, Bye A (1995) Fluticasone propionate - an update on preclinical and clinical experience. Respir Med 89 [Suppl A]: 3-18
15. Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davis D, Pauwels R (1992) Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis 63 [Suppl 122]: 86-95
16. Andersson N, Klint S, Randwall G, Wirén J-E (1994) Equipotency of budesonide and fluticasone propionate in the vasoconstrictor assay. Am J Respir Crit Care Med 149: A467